Neoadjuvant Chemoradiotherapy: Clinical Trials

19 trials of Neoadjuvant Chemoradiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 recruiting, 4 unknown, 2 not yet recruiting. 6 Not applicable, 6 Phase 3, 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Active not recruiting 1, Recruiting 1, Unknown 1
Phase 36Completed 2, Recruiting 2, Not yet recruiting 1, Terminated 1
Phase 25Unknown 3, Recruiting 2
Phase 11Completed 1

Follow Neoadjuvant Chemoradiotherapy: new trials by email Literature Review of Neoadjuvant Chemoradiotherapy trials Research Report on Neoadjuvant Chemoradiotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Neoadjuvant therapy with PD-L1 inhibitor - Esophageal Cancer
Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences6002025-04-012025-03-21
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
Neoadjuvant Chemoradiotherapy, neoadjuvant immunotherapy, Surgery - Esophageal Squamous Cell Carcinoma (ESCC)
Not applicableActive not recruitingRenJi Hospital502024-10-302025-01-07
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy - Rectal Cancer
Phase 3Not yet recruitingSt. James's Hospital, Ireland1002024-10-012023-10-25
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
Cardonilizumab, Paclitaxel, Cisplatin - Esophageal Squamous Cell Carcinoma
Phase 2RecruitingTongji Hospital3362024-01-292026-07-13
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Neoadjuvant Chemoradiotherapy, Adjuvant Chemotherapy, Consolidation Chemotherapy - Rectal Neoplasms
Not applicableRecruitingLarissa University Hospital842022-08-302026-08-26
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Neoadjuvant Chemoradiotherapy, Tislelizumab, Ivor-Lewis or Mckeown Esophagectomy(Mckeown Esophagectomy recommended) - Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III
Phase 2 / Phase 3RecruitingShanghai Zhongshan Hospital1762022-03-022022-06-30
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
Pembrolizumab, Paclitaxel, Cisplatin - Esophageal Squamous Cell Carcinoma
Phase 3RecruitingTianjin Medical University Cancer Institute and Hospital3422021-12-012022-06-01
Long Term Bowel Function Following Rectal Cancer Surgery
chemoradiotherapy - Bowel; Functional Syndrome, Rectal Cancer
Not applicableCompletedMansoura University1712019-08-122022-04-21
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
Neoadjuvant chemoradiotherapy, Oesophagectomy, Neoadjuvant chemotherapy - Radiotherapy Side Effect, Chemotherapy Effect
CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University4232018-11-142020-05-29
Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC
Neoadjuvant immunochemotherapy, Neoadjuvant Chemoradiotherapy - Esophageal Squamous Cell Carcinoma (ESCC)
Not applicableCompletedYongtao Han2002018-03-012025-11-19
Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC
Neoadjuvant Chemoradiotherapy, Adjuvant therapy, Surgery - Esophageal Squamous Cell Carcinoma (ESCC)
Phase 3CompletedYongtao Han2542018-01-012025-01-15
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, Minimally Invasive Esophagectomy - Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0
Not applicableCompletedShanghai Zhongshan Hospital2642017-01-012020-09-10
Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial
neoadjuvant chemoradiotherapy - Circumferential Resection Margin, Intraoperative Perforation of Rectum
Not applicableUnknownBeijing Chao Yang Hospital3502016-12-012021-02-08
Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer
Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy - Gastric Cancer
Phase 3CompletedSun Yat-sen University6202013-06-012025-07-03
Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection
Neoadjuvant Chemoradiotherapy - Non-small Cell Lung Cancer Stage IIIA
Phase 2UnknownZhejiang Cancer Hospital752013-03-012013-08-21
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
Neoadjuvant chemoradiotherapy, Adjuvant chemoradiotherapy - Esophageal Cancer
Phase 2UnknownZhejiang Cancer Hospital602011-10-012013-05-14
Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases
neoadjuvant chemoradiotherapy - Non-small Cell Lung Cancer
Phase 2UnknownShanghai Jiao Tong University School of Medicine802010-08-012010-08-24
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
epirubicin hydrochloride, ifosfamide, sorafenib tosylate - Sarcoma
Phase 1CompletedOHSU Knight Cancer Institute182009-02-012018-09-07
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
transthoracic esophagectomy 2-field extended lymphadenectomy, neoadjuvant chemotherapy (cisplatin, 5-fluorouracil), neoadjuvant chemoradiotherapy - Esophageal Neoplasms, Squamous Cell Cancer
Phase 3TerminatedMinistry of Scientific Research and Information Technology, Poland842001-12-012007-11-16

Conditions studied

Esophageal Squamous Cell Carcinoma (7)  ·  Esophageal Neoplasms (4)  ·  Rectal Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Irritable Bowel Syndrome (1)  ·  Neoplasms (1)  ·  Neoplasms, Squamous Cell (1)  ·  Pathologic Complete Response (1)  ·  Radiation Injuries (1)  ·  Recurrence (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Sponsors

Shanghai Zhongshan Hospital (2)  ·  Yongtao Han (2)  ·  Zhejiang Cancer Hospital (2)  ·  Beijing Chao Yang Hospital (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Larissa University Hospital (1)  ·  Mansoura University (1)  ·  Ministry of Scientific Research and Information Technology, Poland (1)  ·  OHSU Knight Cancer Institute (1)  ·  RenJi Hospital (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  St. James's Hospital, Ireland (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Sun Yat-sen University (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)

Countries

China (13)  ·  United States (2)  ·  Egypt (1)  ·  Greece (1)  ·  Poland (1)

Top investigators

Lijie Tan, MD (2)  ·  Weimin Mao, MD (2)  ·  Christopher W. Ryan, MD (1)  ·  George Tzovaras, Prof (1)  ·  Grzegorz Wallner, MD, PhD (1)  ·  Haiyu Zhou, PhD (1)  ·  Herui Yao, PhD (1)  ·  Konstantinos Perivoliotis, MD (1)  ·  Michael Lanuti, PhD (1)  ·  Zhi-wei Zhou, M.D, Ph.D (1)

Results publications

PMID 14530720, PMID 18320278, PMID 19770374, PMID 20857337, PMID 21084184, PMID 21296855, PMID 21444866, PMID 21684205, PMID 22552194, PMID 24211053, PMID 24266955, PMID 24493117, PMID 24847029, PMID 24876941, PMID 24982463, PMID 25038015, PMID 25180663, PMID 25249141, PMID 25691613, PMID 26254683, PMID 26808342, PMID 28659128, PMID 32637899, PMID 33729467, PMID 35433421, PMID 36400384, PMID 41490111

NIH funding

P30CA069533 (1)